Christian Vasquez is CFO at BioAtla, Inc. (BCAB). They have made 6 open-market trades across 1 company since 2021, most recently 2026-08-31.
CIK 0001835732
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $292K since 2022, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCAB | 10,476 | $19K |
Shares reported on the most recent Form 4, priced at the 2026-09-02 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCAB | BUY | 2023-12-19 | 2023-12-19 | $2.04 | $15K | +26.2% | -1.0% | +11.4% |
| BCAB | BUY | 2023-03-28 | 2023-03-29 | $2.40 | $48K | +40.6% | +31.6% | +19.1% |
| BCAB | BUY | 2022-06-07 | 2022-06-09 | $3.02 | $229K | -8.7% | +20.8% | +166.8% |
| BCAB | SELL | 2021-11-30 | 2021-12-07 | $23.48 | $46K | -15.1% | -31.3% | -76.9% |
| BCAB | SELL | 2021-11-29 | 2021-12-06 | $23.89 | $15K | -15.5% | -24.2% | -76.6% |
| BCAB | SELL | 2021-11-22 | 2021-11-30 | $25.27 | $64K | -15.6% | -19.0% | -74.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.